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Introduction
Mammalian cells have evolved multiple mechanisms for inter-
nalizing fl  uids, surface-bound ligands, and plasma membrane 
components. Although some are well-characterized mechanisms 
such as endocytosis in clathrin-coated pits, many others includ-
ing phagocytosis by nonprofessional phagocytes remain poorly 
 defi  ned. One way to generate new insight into cellular uptake pro-
cesses is to make use of intracellular microorganisms that exploit 
endocytic mechanisms to infect mammalian cells. For example, 
receptor-mediated endocytosis is commonly used by intracellular 
pathogens including bacteria and viruses for  infecting cells (Miller 
and Hutt-Fletcher, 1992; Akula et al., 2003; Gruenheid and   Finlay, 
2003; Pelkmans and Helenius, 2003; Dimitrov, 2004). Apart 
from the convenient transport in vesicles, the acidic environment 
of endocytic vesicles is used by many viruses to effi  ciently pen-
etrate into the host cytosol (Marsh and Helenius, 1989). In the 
case of herpes simplex virus type-1 (HSV-1), endocytosis plays a 
dominant role in infection of many cell types (Nicola et al., 2003; 
Nicola and Straus, 2004). This process, however, appears to be 
unique because it is likely not mediated by formation of clathrin-
coated pits or caveolae and it may not always be pH dependent 
(Gianni et al., 2004; Milne et al., 2005; Nicola et al., 2005).
The other mode of HSV-1 entry is virion fusion at the 
plasma membrane, which is pH independent (Spear, 1993a) and 
is facilitated by at least fi  ve viral glycoproteins: gB, gC, gD, gH, 
and gL (Spear, 1993b). Entry via this mode is initiated by inter-
action of viral gC and/or gB with heparan sulfate (HS) proteo-
glycan (Shukla and Spear, 2001). This interaction is   followed 
by binding of viral gD to one of its receptors (Spear, 1993b). 
The gD receptors include HVEM, a member of the   tumor 
  necrosis factor receptor family; nectin-1 (CD111), a member of 
the Ig superfamily; and 3-O-sulfated heparan   sulfate or 3-OS 
HS (Shukla et al., 1999, 2000; Spear et al., 2000; Xia et al., 
2002). The interaction between gD and its   receptor mobilizes, 
in an unknown fashion, participation from gB, gH, and gL to 
trigger the process of membrane fusion (Spear et al., 2000). 
  Noticeably, the gD receptors are also   essential for entry via 
  endocytosis (Nicola et al., 2003; Nicola and Straus, 2004).
HSV causes conditions ranging from blisters on mucosal 
surfaces to deadly brain infections in immunocompromised indi-
viduals (Shukla and Spear, 2001). It also causes ocular diseases 
affecting not only the outer epithelial layer of the cornea but 
also the stroma and the tissues neighboring the cornea such as the 
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t is becoming increasingly clear that herpesviruses 
can exploit the endocytic pathway to infect cells, yet 
several important features of this process remain 
poorly deﬁ  ned. Using herpes simplex virus-1 (HSV-1) as 
a model, we demonstrate that endocytosis of the virions 
mimic many features of phagocytosis. During entry, HSV-1 
virions associated with plasma membrane protrusions 
  followed by a phagocytosis-like uptake involving re-
arrangement of actin cytoskeleton and trafﬁ  cking of the 
  viri  ons in large phagosome-like vesicles. RhoA GTPase was 
activated during this process and the mode of entry was 
cell type–speciﬁ  c. Clathrin-coated vesicles had no detect-
able role in virion trafﬁ  cking as Eps15 dominant-negative 
mutants failed to affect HSV-1 uptake. Binding and fusion 
of the virion envelope with the phagosomal membrane 
is likely facilitated by clustering of nectin-1 (or HVEM) 
in phagosomes, which was observed in infected cells. 
Collectively, our data suggests a novel mode of uptake 
by which the virus can infect both professional and non-
professional phagocytes.
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  trabecular meshwork (Tiwari et al., 2005) in the eye. Infection of 
the stroma or herpetic stromal keratitis (HSK) is rare, but is a sig-
nifi  cant cause of infectious blindness in the developed countries. 
HSK lasts longer and is more diffi  cult to treat than epithelial kera-
titis (Russell et al., 1984; Thomas and Rouse, 1997). Development 
of novel strategies to effi  ciently treat HSK is hampered by the rel-
atively poor understanding of the infection of the corneal stroma.
To better elucidate the infection of the stroma and to gen-
erate specifi  c information on the endocytic mode of entry, the 
present study compared HSV-1 entry into primary human corneal 
fi  broblasts (CF) cultured from excised tissue of the stroma with 
that of nectin-1 expressing Chinese hamster ovary (nectin-1-CHO) 
cells. Both cell types exhibited a pH-dependent mode of viral 
entry that mimics and retains many features of phagocytosis. 
  Essentially, HSV-1 virions associate with cellular protrusions 
  followed by an actin network–dependent uptake (internalization 
of the virions into the host cytosol) involving RhoA activation. This 
is a novel uptake mode that has implications for entry of virions 
into other professional and nonprofessional phagocytic cells.
Results
Cultured CFs are susceptible to HSV-1 
entry and replication
Monolayer cultures of CF and nectin-1-CHO or HVEM-
  expressing CHO cells (HVEM-CHO) were infected with a re-
combinant β-galactosidase (β-gal)–expressing reporter virus, 
HSV-1(KOS)gL86, abbreviated here as KOS-gL86 and inter-
changeably used in this manuscript for HSV-1. β-gal activity 
indicates that virus has entered the cell, released its genome 
into the nucleus, and activated the constitutive promoter for the 
enzyme production and activity (Shukla et al., 2000). Although 
no β-gal activity (Fig. 1 A, top) was observed in naturally 
  resistant wild-type CHO-K1 cells (CHO-WT), dosages of 
  input virus suffi  cient to infect 100% of nectin-1-CHO cells 
(Fig. 1 A, middle) also caused β-gal expression in 100% of 
the CF cells (Fig. 1 A, bottom). The viral dose-response curve 
for CF, performed in the linear range of 0–100 PFU/cell, was 
similar to that of nectin-1-CHO or HVEM-CHO cells and 
naturally susceptible HeLa cells (Fig. 1 B). CHO-WT cells 
transfected with an empty vector pcDNA3 were used as a 
negative control (Fig. 1 B). As a measure of productive infec-
tion, HSV-1 replication was verifi  ed by real-time PCR using 
HSV-1 gD probes and also by syncytial plaque formation. The 
viral DNA replications were indicated by threshold cycle (CT) 
values: the lower the value, the higher the viral replication. 
In CF, the highest replication was seen at 36 h, which was 
also verifi  ed by PCR (Fig. 1, C and D). The HSV-1 virions 
were also able to form plaques and the numbers of plaques 
formed (unpublished data) were very similar for CF and 
  nectin-1-CHO cells (Fig. S1, A–C, available at http://www.
jcb.org/cgi/content/full/jcb.200509155).
Figure 1.  Corneal ﬁ  broblasts (CF) exhibit susceptibility 
to HSV-1 entry. (A)  β-galactosidase staining of viral 
entry. CHO-WT (top panel), nectin-1-CHO (middle panel) 
and CF (bottom panel) cells were exposed to a recom-
binant β-galactosidase-expressing HSV-1 (5 PFU/cell) for 
6 h followed by incubation with X-Gal (5-bromo-4-chloro-
3-indoyl-β-D-galactoside) to identify infected cells (blue). 
(B) HSV-1 entry curves. As indicated, CF, HeLa, nectin-1-
  CHO, HVEM-CHO, or pCDNA3-CHO (control) cells in 
microwells were exposed to HSV-1 at the dosages and 
time point indicated followed by incubation with ONPG 
(O-nitro-phenyl β-D-galactopyranoside) which is cleaved 
by β-gal to galactose and O-nitro-phenol. The individual 
OD values were within 10% of the mean and represent 
the amount of reaction product detected by spectropho-
tometry (OD 410 nm). (C) Replication of HSV-1 in human 
CF. Real time PCR shows replication of HSV-1 DNA in 
nectin-1-CHO and CF at times 12, 24, and 36 h. Mock 
infected cells were used as controls. Fluorescence curve 
along with CT (threshold cycle; vertical red lines) values 
are shown for each sample. The parameter CT is deﬁ  ned 
as the fractional cycle number at which the ﬂ  uorescence 
passes the ﬁ  xed threshold. (D) Visualization of viral DNA. 
PCR products electrophoresed on 1.5% agarose gel are 
shown. The ampliﬁ   ed products (HSV-1 gD) were of the 
predicted size (129 bp*). The molecular size standards 
are shown in the ﬁ  rst lane from left.PHAGOCYTOSIS-LIKE UPTAKE OF HSV-1 • CLEMENT ET AL. 1011
Plasma membrane protrusions facilitate 
viral entry
Ultrastructural analyses of HSV-1 entry into CF and nectin-1- 
CHO cells using EM suggested a role for plasma membrane 
protrusions and vesicles in entry. Transmission EM (TEM) 
micrographs demonstrated enveloped virions adjacent to and/or 
surrounded by protrusions of the plasma membrane in both 
nectin-1-CHO cells (Fig. 2, A and B, arrows) and CF (Fig. 2, 
D and E). The internalized virions were enveloped and located 
in uncoated and relatively large vesicles (Fig. 2, A, B, C, E, 
and F) not in clathrin-coated pits as seen in typical endocytosis. 
In contrast, HSV-1–infected primary cells cultured from excised 
human trabecular meshwork tissues (TM cells) had relatively 
few protrusions (Fig. 2 K) and the virions were mainly at-
tached to relatively smooth cell surfaces (Fig. 2, G and H, 
  arrows). Intracellular vesicles containing virions were virtually 
absent in TM cells. The lower magnifi  cation views for all three 
cell types are shown in Fig. S2 (available at http://www.jcb.
org/cgi/content/full/jcb.200509155).
Scanning EM (SEM) results correlated TEM observations 
that many HSV-1 virions (Fig. 2, I and J, arrows) were attached 
to the protrusions seen on nectin-1-CHO cells (arrowheads). 
The protrusions were  5–30 μm long and rarely branched, 
mainly seen within 30 min of exposure to virus. Immunogold 
EM of HSV-1 envelope glycoproteins gD or gH–gL further 
 confi  rmed that enveloped HSV-1 virions associated with the 
Figure 2.  Electron microscopic analysis of HSV-1 entry. TEM (A–H) and SEM (I–J) were performed to analyze HSV-1 entry into cells. Unless otherwise 
stated, all the images were captured 30 min after infection. (A) Virions (arrows) either bound to a nectin-1-CHO cell surface or loaded in vesicles, bar 0.4 μm. 
(B) Engulfment of virions (arrow) by protrusions present on the surface of a nectin-1-CHO cell, bar 0.5 μm. (C) Vesicles in nectin-1-CHO cell containing 
  enveloped virions (arrows), bar 0.4 μm. (D–F) CF with membrane protrusions in the vicinity of HSV-1 virions and some enveloped virions in vesicles 
(arrows), bar 2 μm. (G) Virions (arrows) attaching to a protrusions-less cell surface of a TM cell, bar 0.8 μm. (H) Virions bound and apparently fusing 
with the plasma membrane of a TM cell, bar 2 μm. (I) Plasma membrane protrusions (arrowheads) from nectin-1-CHO with attached virions (arrows), bar 1 μm. 
(J) Virions (arrows) attached to a nectin-1-CHO protrusion, bar 100 nm. (K) Determination of percentage of plasma membrane protrusions scored from sam-
pled groups of 250 single cells or clusters (with 5–20 cells),  5 μm length of a protrusion and at least 5% of the cell surface covered with protrusions is 
scored positive.JCB • VOLUME 174 • NUMBER 7 • 2006  1012
protrusions on nectin-1-CHO cells and localized in the intra-
cellular vesicles (unpublished data). No coated pits or caveolae 
(“smooth coated” or “non-coated” omega- or fl  ask-shaped 
  invaginations) were observed.
Intracellular vesicles containing 
HSV-1 virions are not formed 
from clathrin-coated pits
To completely rule out endocytosis of HSV-1 in clathrin-coated 
vesicles, dominant-negative EGFR pathway substrate clone 15 
(Eps15) mutants were used (Fig. 3). Eps15, a constituent of 
plasma membrane clathrin-coated pits, is ubiquitously and con-
stitutively associated with AP-2 (Benmerah et al., 1998, 1999). 
AP-2, clathrin, and dynamin are three major coat proteins. The 
AP-2 complex plays a principal role in both the organization 
and function of plasma membrane coated pits; it drives clathrin 
assembly onto the plasma membrane and interacts with tyro-
sine based signals of membrane receptors. Clathrin provides an 
organizing framework to the pit. Dynamin is a GTPase that as-
sembles into rings at the neck of invaginated coated pits and its 
GTPase activity is necessary for the scission of the vesicle from 
the plasma membrane (Mellman, 1996; Schmid, 1997; McNiven, 
1998). Dominant-negative mutants of Eps15 inhibit clathrin-
dependent endocytosis (Carbone et al., 1997; Benmerah et al., 
1998). The mutants used were: DIII∆2 (control), a C-terminal 
domain construct of Eps15 lacking all the AP-2–binding sites 
that does not interfere with endocytosis; DIII, the C-terminal 
domain construct of Eps15 containing all the AP-2 binding sites 
(Benmerah et al., 1996; Iannolo et al., 1997), which blocks 
  endocytosis (Benmerah et al., 1998), and E∆95/295 or EH29, the 
construct lacking Eps15 homology (EH) domains at the N-
  terminal that are required for clathrin-coated pit targeting of Eps15 
and thus an inhibitor of clathrin-coated pit assembly (Benmerah 
et al., 1999). These controls and mutants, when transfected into 
nectin-1-CHO cells, all failed to block virus entry (Fig. 3 A). 
The transfection effi  ciency estimated by GFP expression (Fig. 
3 B) was at an appropriate level of 60%. In parallel experiments, 
the dominant-negative mutants DIII and E∆95/295 expectedly 
blocked human herpes virus-8 (HHV-8) entry of 293T cells 
(Fig. 3 C) as HHV-8 is known to use endocytosis via clathrin-
coated pits for entry (Akula et al., 2003).
HSV-1 induces uptake of an established 
phagocytic tracer
Absence of any clear evidence supporting endocytosis in coated 
pits and the development of protrusions in response to HSV-1 
entry raised the possibility that virus entered into nectin-1-CHO 
and CF via a phagocytosis-like uptake. To test this possibility, 
we used an assay that allows the phagocytosis process to be ob-
served and quantitated in cells. Essentially, the internalization 
of fl   uorescently labeled bacteria such as fl  uorescein-labeled 
K-12  Escherichia coli ( E. coli bioparticles) was monitored. 
  After quenching of the extracelluar fl  uorescence by trypan blue, 
the assay measures intracellular fl  uorescence emitted by the 
  engulfed particles (Sahlin et al., 1983; Wan et al., 1993). The 
phagocytosis assays (Fig. 4, A and B) were performed using 
nectin-1-CHO, HVEM-CHO, and a CHO mutant (CHO-745 or 
pgsA-745) transfected with nectin-1 or HVEM. CHO-745 cells 
lack glycosaminoglycans including HS (Esko et al., 1985). Be-
cause HS is required for HSV-1 attachment to cells (Shukla and 
Spear, 2001), the purpose of this experiment was to determine if 
the induction of phagocytosis was dependent on virus attach-
ment to cells. As predicted, exposure of HSV-1 to nectin-1-CHO 
and HVEM-CHO elicited several hundred-fold induction of 
phagocytosis activity compared with the unexposed cells (Fig. 4 A). 
A similar but somewhat muted response was observed with 
CHO-745 cells transfected with the same receptors, which 
showed only about a 10-fold increase in the phagocytosis activity 
Figure 3.  Eps15 mutants do not inhibit HSV-1 entry. (A) Effect of ex-
pression of Eps15 mutants. The nectin-1-CHO cells were transfected 
with either empty vector pcDNA3 or expression plasmids for Eps15 
  mutants (as indicated) followed by infection with HSV-1 (5 PFU/cell). 
The entry was measured by β-galactosidase activity. Entry is presented 
as a percentage of the entry into untransfected cells. (B) Determination 
of transfection efﬁ   ciency of plasmids-expressing GFP tagged Eps15 
  mutants (indicated) into nectin-1-CHO cells. Shown are the snapshots 
of GFP expressing cells. (C) Effect of the expression of Eps15 mutants 
on HHV-8 entry. 293 cells were either infected (+) or mock infected (−) 
with HHV-8 (5 PFU/cell). Un-internalized virions were removed from cell 
surface using citrate buffer (pH 3). After permeabilization, a mouse 
monoclonal antibody against HHV-8 glycoprotein, K8.1A (1:500) 
along with biotinylated secondary antibody and streptavidin-  conjugated 
horseradish peroxidase were used in an ELISA to measure entry using 
a spectrophotometer. The reaction products generated by the mu  tants 
are shown as percentage of control values obtained in triplicates for 
HHV-8 infected (+) and pcDNA3 transfected cells. Asterisks indicate 
signiﬁ  cant difference from controls (P < 0.05, t test), error bars repre-
sent SD.PHAGOCYTOSIS-LIKE UPTAKE OF HSV-1 • CLEMENT ET AL. 1013
(Fig. 4 A). Thus, it appears that HS-mediated attachment of 
  virions (normally mediated by HSPG) to cells is needed for 
maximal triggering of phagocytosis. Partial, HS-independent 
attachment of virions to cells does occur in the presence of 
HSV-1 gD receptors; therefore, complete loss of phagocytosis 
was not expected (Shukla et al., 1999).
To gain further insight into the mechanism, we focused 
on the ubiquitously expressed dynamin-2 isoform of dynamin, 
which, as indicated earlier, is crucial for regulation of the ac-
tin dynamics at the plasma membrane and for detachment of 
intracellular vesicles including phagosomes from the plasma 
membrane (Nichols and Lippincott-Schwartz, 2001; Meier and 
Greber, 2003; Schafer, 2004). We focused on dynamin also be-
cause it is considered to be essential for phagocytosis but not 
for macropinocytosis (Meier and Greber, 2003), and could po-
tentially be used to differentiate the two processes. Although 
nectin-1-CHO cells transfected with WT-dyn2 or its dominant-
negative mutant, K44A-dyn2, exhibited signifi  cant enhancement 
of phagocytosis activity in the presence of HSV-1 virions (Fig. 
4 B), there was a moderate yet signifi  cant ( 25%) decrease in 
the phagocytosis activity by K44A expression. Given a 50–60% 
transfection effi  ciency, the net decrease in the phagocytosis ac-
tivity could be close to 50% if all the cells were expressing the 
mutant. Thus, dyn2-mediated membrane pinching might play 
a role in HSV-1 uptake via a phagocytosis-like mechanism. Next, 
to evaluate how this drop in phagocytosis could be translated 
into viral entry, we performed an entry assay. Unlike WT-dyn2, 
which showed the same effect on entry as transfection with 
an empty plasmid, the expression of K44A-dyn2 resulted in a 
signifi  cant (60% or more) decrease in HSV-1 entry (Fig. 4 C). 
Again, when extrapolating to 100% transfection effi  ciency, the 
data would indicate signifi  cant blocking of entry in the presence 
of the mutant and may implicate dynamin-mediated processes 
in HSV-1 internalization.
Figure 4.  Induction of phagocytosis during HSV entry and the role of 
  dynamin2. Phagocytosis of E. coli K-12 bioparticles was measured in rela-
tive ﬂ  uorescence units (RFU) using 480 nm excitation and 520 nm emission 
with (+) or without (−) HSV-1. (A) Effect of HSV-1 on phagocytic activity 
of nectin-1 (or HVEM)-CHO or CHO-745 cells naturally deﬁ  cient in HS. 
(B) Effect of K44A-dyn2 or WT-dyn2 expression on phagocytic activity of 
nectin-1-CHO cells. (C) Effect of expression of K44A-dyn2 or WT-dyn2 ex-
pression on virus entry in nectin-1-CHO cells. The data shown are the means 
of   triplicate measures and are representative of 3 independent experiments. 
Asterisks indicate signiﬁ   cant difference from controls (P < 0.05, t test), 
  error bars represent SD.
Figure 5.  GFP tagged HSV-1 and red ﬂ  uorescent beads are cointernalized. 
Nectin-1-CHO cells were either (A) mock treated or (B) treated with Cyto D, 
before exposure to green ﬂ   uorescent HSV-1 (K26GFP) and latex beads 
(Red-beads). Sequential CM was performed to examine z-stacks for virus 
and beads internalization and colocalization (Merge). A higher magniﬁ  ca-
tion of the merged images is also shown (bottom panels).JCB • VOLUME 174 • NUMBER 7 • 2006  1014
HSV-1 virions and phagocytic tracers 
are cointernalized in an actin 
network–dependent process
HSV-1 induction of bioparticle internalization via phago-
cytosis does not necessarily imply that the virions themselves 
get   internalized using the same route unless a colocalization is 
demonstrated. To determine whether the virus cointernalized with 
phagocytic tracers such as red fl  uorescent latex beads, a series 
of colocalization experiments was performed. CF or nectin-1-
CHO cells were either treated with cytochalasin D (Cyto D), 
an inhibitor of actin polymerization and phagocytosis (Gottlieb 
et al., 1993; Rabinovitch, 1995; Schafer, 2004), or mock-treated 
before coincubation with red fl  uorescent beads and a recombi-
nant HSV-1 (K26GFP). The recombinant virus contains nucleo-
capsid tagged with GFP (Desai and Person, 1998) that allows 
monitoring of the virus internalization into host cytosol (virus 
entry) using fl  uorescent confocal microscopy (CM). Non-
  internalized virions were removed by low pH treatment (citrate 
buffer pH 3) (Fig. S3, available at http://www.jcb.org/cgi/
content/full/jcb.200509155). Using CM, z-stacks were generated 
and analyzed for internalization of both the virions (green) and 
the tracer (red). Indeed, in mock-treated cells, virions cointer-
nalized with beads (Fig. 5 A, yellow), although a few clusters 
of virions were also noted to have entered into cells without the 
beads. It was not totally unexpected because the virus, in its 
capacity as an inducer, could potentially invoke its own inter-
nalization via phagocytosis-like uptake without the tracer. With 
Cyto D treatment, internalization of both virions and the tracer 
was signifi  cantly restricted, as very few virions and/or beads 
were seen (Fig. 5 B). Overall, the fi  nding that the virions and 
the phagocytic tracers were cointernalized suggests that phago-
somes may be the vesicles that transport HSV-1 virions during 
the entry.
Given that Cyto D blocked cointernalization of virions 
and the beads, we next determined whether the actin inhibitors 
would also block entry of HSV-1 independent of the beads. 
Cyto D and another actin inhibitor, latrunculin B (Lat B) (Spector 
et al., 1989) were used. Although without showing any de-
tectable effect on TM cells (Fig. 6 A), Cyto D blocked in a 
 dose-dependent manner up to 80% of HSV-1 entry into nectin-1-
CHO (or HVEM-CHO) and CF (Fig. 6 A). The latter ex-
presses HVEM and 3-OS HS, but not nectin-1 (unpublished 
data). Likewise, Lat B in a dose-dependent manner blocked up 
to 60% of HSV-1 entry into nectin-1-CHO and CF, but did not 
affect entry into TM cells (Fig. 6 B).
To further demonstrate the signifi  cance of actin network 
in HSV-1 entry, cells were treated with Cyto D or Lat B either 
after (post-treatment) or before (pre-treatment) infection with 
HSV-1. It was postulated that pre-treatment would have more 
negative effect on entry than post-treatment, provided the actin-
based protrusions (such as fi  lopodia) played a role in the virus 
attachment to cells as well. After allowing for attachment and 
internalization of virions in both cases, cell surface virions that 
failed to infect were removed using low pH (citrate buffer pH 3.0) 
(Fig. S3). The internalization of the virus HSV-1 (K26GFP) 
was quantitated by measuring fl  uorescence intensity. There was 
 60–75% inhibition of internalization of HSV-1 in CF and 
  nectin-1-CHO cells in post-treatment and up to 90% in pre-
treatment cells (Fig. 6 C). TM cells did not exhibit signifi  cant 
inhibition in either case. Corresponding effects on phagocytosis-
like uptake paralleled that of internalization (Fig. 6 D). It should, 
however, be noted that experiments using Cyto D and Lat B are 
suggestive, but not fully conclusive, of the role of actin network 
and phagocytosis-like uptake of HSV-1 because the drugs may 
have other effects not fully accounted for by the experiments 
shown here.
Figure 6.  Actin depolymerizers block HSV-1 
internalization.  Cells were treated with indi-
cated concentrations of Cyto D and Lat B and 
exposed to HSV-1 (50 PFU/cell). (A) Effects of 
Cyto D on viral entry into nectin-1-CHO, CF 
and TM cells. (B) Effects of Lat B on viral entry 
into nectin-1-CHO, CF and TM cells. The control 
(Control) represents entry into corresponding 
mock-treated cells. (C) Effect of Cyto D and 
Lat B on virus internalization. As indicated cells 
were treated with Cyto D or Lat B at concentra-
tions indicated for 2 h either after (post-treatment) 
or before (pre-treatment) exposure to HSV-1 
(indicated). The assays were performed either 
with (+) or without (−) indicated components. 
Internalization of virions at 37°C after pH 3.0 
treatment was quantitated by determining rela-
tive ﬂ   uorescence units (RFU) using a 96-well 
ﬂ  uorescence reader. (D) Effect of Cyto D and 
Lat B on HSV-1 dependent phagocytosis-like 
uptake of green ﬂ  uorescent E. coli bioparticles. 
The extracellular ﬂ   uorescence was quenched 
by treatment with trypan blue. The data shown 
are the means of triplicate measures and are 
representative of 3 independent experiments. 
Asterisks indicate signiﬁ   cant difference from 
controls and/or treatments (P < 0.05, t test), 
error bars represent SD.PHAGOCYTOSIS-LIKE UPTAKE OF HSV-1 • CLEMENT ET AL. 1015
Effect of pH on HSV-1 entry
We also examined the pH dependence of this mode of entry. 
Nicola et al. (2003) have previously found that HSV-1 entry into 
nectin-1-CHO or HVEM-CHO is pH dependent. Thus, effects 
of lysosomotropic agents capable of interfering with vesicular 
acidifi   cation were tested. These included bafi  lomycin A1 
(BFLA-1) (Lukacs et al., 1990; Perez and Carrasco, 1994; 
Drose and Altendorf, 1997), chloroquine, and ammonium 
  chloride (de Duve et al., 1974). Monolayer cultures of nectin-1-
CHO or HVEM-CHO, CF, and TM cells were pretreated with 
BFLA-1 or chloroquine. In addition, ammonium chloride was 
applied to CF and TM cells. There was a strong dosage-dependent 
inhibition of HSV-1 entry by these drugs in nectin-1-CHO 
(Fig. 7 A) and CF (Fig. 7 B); the inset shows the inhibitory 
  effects of intermediate concentrations of chloroquine. Noticeably, 
entry into TM cells was inhibited by chloroquine, but not by 
BFLA-1 or ammonium chloride (Fig. 7 C). Collectively, the in-
hibition of acidifi  cation of vesicles severely retarded viral entry 
into CF and nectin-1-CHO, but not into TM cells.
Receptor clustering and the presence 
of the virions in early stage vesicles
The gD receptor (nectin-1 or HVEM) is essential for HSV-1 
  entry (Spear et al., 2000). To understand its role in phagocytosis-
like uptake mode, we hypothesized that it should be present in 
the vesicles to facilitate viral capsid penetration into the cytosol, 
for which it is already known to be required (Pertel et al., 2001). 
To trace receptor traffi  cking we used a chimera of full-length 
nectin-1 and enhanced GFP (nectin-1-EGFP). This chimera is 
a functional receptor for HSV-1, which maintains full entry 
and cell-to-cell fusion activities (unpublished data). CHO cells 
transiently transfected with the chimera (nectin-1-EGFP-CHO) 
were briefl  y serum starved to eliminate endogenous trans-
ferrin and subsequently replaced with an exogenous Texas red 
conjugate (Texas red-transferrin), a molecule recycled via early 
endosomal vesicles including phagosomes (Dautry-Varsat, 1986; 
Tjelle et al., 2000). Incorporation of nectin-1 into vesicles was 
traced by sequential CM to eliminate the “cross talk” or leakage 
between green and red, allowing for a factual colocalization. 
In mock-infected nectin-1-EGFP-CHO (Fig. 8 A, a–c), nectin-1-
EGFP (green) and Texas red-transferrin  –positive vesicles (red) 
were noted throughout the cells, but the nectin-1 and vesicles 
appeared at distinct diffuse areas with little colocalization. 
However, when nectin-1-EGFP-CHO cells were infected with 
purifi  ed HSV-1 (Fig. 8 A, d–f), large clusters of nectin-1 (green) 
and Texas red-transferrin–positive vesicles were observed (red). 
Their colocalization (yellow) was indicative of the association 
of nectin-1 with the vesicles.
To verify the presence of the virions in the vesicles and to 
evaluate the stage at which virions transit from vesicles to re-
lease their capsid into the cytosol, antibodies to early endosome 
antigen 1 (EEA1) (marker for early stage endosomes and/or 
phagosomes) (Gillooly et al., 2001, Amer and Swanson, 2002), 
transferrin receptor (TfR) (marker for recycling endosomes), 
and LAMP-2 (marker for lysosomes) were independently used 
to stain infected (or mock-infected control) nectin-1-CHO or 
CHO-WT cells. Entry was with cold bound K26GFP incubated 
in media at 37°C over a time course ranging from 0 to 90 min. 
Signifi  cant numbers of virions (green) were found to localize in 
vesicles that mimic early stage endosomes (red) at time points 
from 5 to 60 min, with a peak seen at 30 min (Fig. 8 B). This 
time course corresponded well with the HSV-1 internalization 
observed while estimating optimal phagocytosis-like uptake 
(unpublished data). It appears that the virus stabilizes these 
early stage vesicles to facilitate its transit into the cytosol. Little 
colocalization of virus with both TfR (Fig. 8 B) and LAMP-2 
(unpublished data) was observed, suggesting that neither was 
signifi  cantly involved in virion traffi  cking.
Figure 7.  Lysosomotropic agents block HSV-1 entry. Cells were treated 
with indicated concentrations of baﬁ   lomycin A1 (BFLA-1), chloroquine 
(Chloro), or ammonium chloride (NH4Cl), and exposed to HSV-1 (50 PFU/
cell). Viral entry was quantitated at 3 h after infection. The data shown are 
the means of triplicate measures and are representative of three indepen-
dent experiments. The control (Control) represents entry into corresponding 
mock-treated cells. (A) Effects of lysosomotropic agents on entry into 
nectin-1-CHO cells. (B) Effects of lysosomotropic agents on entry into CF. 
The inset shows the effect of intermediary concentrations of chloroquine, 
a commonly used drug for the treatment of malaria. (C) Effects of lysosomo-
tropic agents on entry into TM cells. Asterisks indicate signiﬁ  cant differ-
ences from corresponding mock-treated controls (P < 0.05, t test), error 
bars represent SD.JCB • VOLUME 174 • NUMBER 7 • 2006  1016
Cellular signaling supports a phagocytosis-
like entry
Plasma membrane protrusions that are formed in response to 
HSV-1 entry may be triggered by upstream signaling. Potential 
candidates may include tyrosine kinases (Cheshenko et al., 
2005) and lipid kinases. Pharmacological agents such as ge-
nistein (Nicola et al., 2005), a tyrosine kinase inhibitor, and 
wortmannin, a specifi  c PI3-kinase inhibitor (Nicola and Straus, 
2004), were used to assess the requirements for signaling. Both 
genistein and wortmannin adversely affected entry of HSV-1 
into CF, nectin-1-CHO, and TM cells. However, the inhibitory 
effects were more pronounced in CF and nectin-1-CHO than in 
TM cells. Genistein at the higher dosage of 400 μM was more 
effective (Fig. S4 A, available at http://www.jcb.org/cgi/content/
full/jcb.200509155). It might be that the less potent effect 
of wortmannin ( 50–60%) at the higher dosage of 100 nM 
was because it acted downstream (Fig. S4 A). Therefore, we 
performed dose-response entry experiments using nectin-1-CHO 
cells and found that genistein (Fig. S4 B) but not wortmannin 
(Fig. S4 C) induced a dose-dependent inhibition that signifi  -
cantly blocked HSV-1 entry. In further experiments, genis-
tein blocked cointernalization of K26GFP and red beads but 
wortmannin failed to do so (unpublished data). Tyrosine kinase 
activation may play a role in HSV-1 uptake into CF and nectin-1-
CHO cells.
We next examined the role of Rho family GTPases that 
are known to regulate the actin cytoskeleton rearrangement 
that drives the process of phagocytosis. RhoA is required for 
complement-mediated phagocytosis and Rac and/or Cdc42 typ-
ically are implicated in triggered phagocytosis (Caron and Hall, 
1998). Rho alternates between the active GTP-bound and inac-
tive GDP-bound state. Using the substrates GDP (negative control), 
GTPγS (positive control), and purifi  ed HSV-1 (potential acti-
vator of Rho) and pull-down assay we found that RhoA was 
  activated in infected CF and nectin-1-CHO cells (Fig. 9 A). 
A time-course study using nectin-1-CHO cells indicated that 
the RhoA activation was sustained for 30 min (Fig. 9 B). 
  Incidentally, this time frame matches well with the localization 
of the virions within early stage vesicles (Fig. 8 B). Cdc42 activa-
tion was not sustained. This activation dissipated in nectin-1-
CHO cells within roughly 5 min of virus exposure (Fig. 9, 
C and D). Some of the plasma membrane protrusions were fi  la-
mentous and rarely branched suggesting transitory fi  lopodia 
formation, potentially to facilitate virus attachment. Similarly, 
no activation of Rac1 was detected (Fig. 9, E and F). These data 
prompted us to look more closely at changes in actin cytoskeleton 
upon viral exposure. Stress fi  bers became more prominent 
with entry of nectin-1-CHO cells, peaking at 30 min (Fig. S5, 
available at http://www.jcb.org/cgi/content/full/jcb.200509155). 
This time period, matching with that observed in RhoA activa-
tion and virion traffi  cking experiments, may be critical for viri-
ons transit via vesicles.
Discussion
The study presented herein attempts to shed light on many im-
portant but yet unclear aspects of a recently described endocytic 
route of HSV-1 entry (Nicola et al., 2003). Our work began with 
Figure 8.  HSV-1 induced clustering of receptor 
and identiﬁ  cation of virions containing vesicles. 
(A) Nectin-1 colocalizes with early stage vesi-
cles in HSV-1 infected cells. CHO cells trans-
fected with a plasmid expressing nectin-1-EGFP 
were incubated with Texas red-transferrin 
  conjugate (1:250) for 10 min and then either 
(a–c) mock infected or (d–f) infected with 
HSV-1 (50 PFU/cell) for 30 min, ﬁ  xed  and 
  examined by confocal microscopy. Nectin-1 
expression is seen in green (a and d) and the 
early stage vesicles appear red (b and e). In 
mock-infected cells, merger of green and red 
shows no colocalization (c), but in infected 
cells there is colocalization (yellow) (f); 
(B) HSV-1 colocalizes in early stage vesicles. 
As indicated, nectin-1-CHO or CHO-WT (Con-
trol) cells were infected with HSV-1 (K26GFP) 
(green) for the time points indicated and then 
treated with citrate buffer (pH 3) and ﬁ  xed. It 
was followed by staining with either anti-EEA1 
or anti-TfR (red) to identify the vesicles. By se-
quential CM the z stacks show colocalization 
of virions with early stage vesicles. Little colo-
calization with recycling to late endosomes 
was observed.PHAGOCYTOSIS-LIKE UPTAKE OF HSV-1 • CLEMENT ET AL. 1017
a goal to examine the ability of cultured human CF to support a 
productive HSV-1 entry, but it ended up with systematic explo-
ration of the endocytic mode of entry. This cell type–dependent 
viral uptake was unexpectedly found to share many features of 
professional phagocytosis, hence the name “phagocytosis-like.” 
It likely requires actin rearrangement and dynamin assembly 
and is regulated by signaling pathways that apparently involve 
action of RhoA GTPase and may also involve tyrosine kinases. 
This pH-dependent and clathrin-independent viral uptake 
mechanism is marked by generation of cell surface protrusions 
in response to HSV-1 entry and clustering of gD receptors in 
large phagosome-like vesicles. Consistent with the notion that 
HSV-1 entry could occur by a phagocytosis-like uptake, it was 
found that the virus can signifi  cantly induce phagocytosis of 
E. coli bioparticles and HSV-1 virions cointernalized with 
phagocytic tracers.
Induction of phagocytosis by HSV-1 might seem un-
expected because it is generally believed that phagocytosis 
could not be induced by particles smaller than 0.5 μm in dia-
meter (Rabinovitch, 1995; Sansonetti, 2001). The enveloped 
HSV-1 is only  0.2 μm. Yet evidence does exist to the contrary 
that phagocytosis could ensue for tracers as small as 0.13 μm 
(Desjardins and Griffi  ths, 2003). Actually, it has been reported 
that granulocytes take up HSV via complement-mediated 
phagocytosis (Van Strijp et al., 1989). Also in the past, phago-
cytosis has been implicated in entry of viruses including many 
paramyxoviruses smaller in size than HSV-1 (Silverstein and 
Marcus, 1964). In addition, certain forms of vaccinia virus use 
an entry pathway that mimics the initial stages of phagocytosis 
(Locker et al., 2000). Similarly, the induction of RhoA GTPase 
during HSV-1 entry (Fig. 9, A and B) but not Cdc42 or Rac1 
(Fig. 9, C–F) would support the notion that the mechanism 
of entry into nectin-1-CHO and CF could be analogous to 
  complement-activated phagocytosis (Caron and Hall, 1998). 
It is perhaps logical to suggest that the molecular signaling 
mechanisms, not necessarily size, invokes phagocytosis.
Our fi  ndings supported by some additional ultrastructural 
images allow us to propose a model (Fig. 10). In brief, the infec-
tion of nectin-1-CHO and CF cells begins with the virions 
  making initial contact with the cell surface by associating with 
plasma membrane protrusions (may include fi  lopodia) (Fig. 10, 
arrows, top left and right panels). As the virions surf to concen-
trate at the cell body, internalization may occur by phagocytosis-
like uptake followed by transport in early stage vesicles that are 
Figure 9.  Activation of RhoA signaling pathway by HSV-1. Western blot analysis of Rho GTPases. Activation of RhoGTPases (indicated) in the presence 
of GDP, GTPγS as controls or HSV-1 in cell types (indicated) was determined by afﬁ  nity precipitation with Rhotekin-RBD-GST or PAK-PBD-GST beads 
(described in Materials and methods). (A) Activation of RhoA by HSV-1 at 15 min after infection. (B) Time course of HSV-1 induced activation of RhoA 
from 0 to 90 min in nectin-1-CHO cells. (C) Activation of Cdc42 by HSV-1 at 15 min after infection. (D) Time course of HSV-1 induced activation of Cdc42 
from 0 to 10 min in nectin-1-CHO cells. Transient activation of Cdc42 was observed between 1–5 min (E) Activation of Rac1 by HSV-1 at 15 min after 
  infection. (F) Time course of HSV-1 induced activation of Rac1 from 0 to 10 min in nectin-1-CHO cells. As evident, no HSV-1 induced activation of Rac1 
was observed.JCB • VOLUME 174 • NUMBER 7 • 2006  1018
likely phagosomes, as suggested by their relatively large 
size  and apparent colocalization of HSV-1 with phagocytic 
tracers (Fig. 5). Presence of nectin-1 (or HVEM) in the vesicles 
(Fig. 8 A, d–f) could provide the opportunity for the virions to 
fuse their envelopes with the vesicular membrane (Fig. 10, 
  middle top and bottom panels). Consistent with a possibility that 
low pH environment found in vesicles can, in fact, enhance the 
fusion potential of HSV-1 virions, exposure of gB and gD to 
acidic pH has been shown to improve their membrane fusion 
potential (Butcher et al., 1990) and similarly, we have also 
found that low pH shock enhances HSV-1 mediated cell-to-
 cell  fusion (unpublished data). The fi  nal stage is the release of 
the naked nucleocapsid (arrowhead) from the vesicle into the 
cytosol (cy) proximal to the nucleus (nu) (Fig. 10, bottom) for 
replication in the nucleus.
Our model raises an obvious question related to the initial 
molecular events that trigger phagocytosis-like uptake. Specifi  c 
virus–cell interactions are likely to be important because HS-
mediated attachment of virus to cells is needed for maximal 
  induction of phagocytosis-like uptake. Association with HS, 
however, is likely not the trigger, as cells lacking HSPG can still 
induce some basal level of phagocytosis (Fig. 4 A). Similarly, gD 
receptors (nectin-1, HVEM) may not be directly involved 
  because they appear to be essential for entry into all cells, irre-
spective of the mode of viral entry (Nicola and Straus, 2004). 
Based on the current theory that RhoA is usually activated in 
complement mediated phagocytosis (Caron and Hall, 1998), it 
is possible that either an unknown complement receptor homo-
logue, or a CF and CHO analogue of it, could trigger a similar 
process. The search for the trigger is further complicated by the 
existence of a dozen or so different HSV-1 envelope glycopro-
teins with little known functions. One or perhaps more of these 
HSV-1 envelope glycoproteins are likely to be needed for the 
triggering mechanism. Precedent exists, at least for some intra-
cellular bacteria, that interactions with integrins (and potentially 
HS) could signal internalization by phagocytosis after binding 
of pathogens (Rabinovitch, 1995; Fukasawa et al., 1997; Tjelle 
et al., 2000). Interestingly, a glycoprotein (gH) essential for 
HSV-1 entry has recently been reported to interact in vitro with 
αvβ3 integrins, although the effect of this interaction on entry 
is still unclear (Parry et al., 2005). Moreover, new fi  ndings in-
cluding ours indicate that the mode of entry could vary with 
cell types (Nicola et al., 2005). Conceivably, the functions of 
various HSV-1 glycoproteins and their corresponding receptors 
Figure 10.  Model for the phagocytic mode of HSV-1 entry. 
A cartoon (blue) illustrates the major steps (a-e) involved in 
the phagocytosis-like mode of HSV-1 entry. The panels on the 
right provide additional ultra-structural evidence to support 
the model. Top panels: Interaction of HSV-1 (arrows) with 
  nectin-1-CHO cell membrane protrusions. Observations were 
made by SEM (top left panel, bar 1.0 μm) and by CM (top 
right panel, bar, 8.0 μm). Middle panels: viral trafﬁ  cking. 
TEM images of a virus (arrow) apparently engulfed by the 
protrusions (top panel) and potentially fusing with the vesicu-
lar membrane (bottom panel); bar, 0.6 μm. Bottom panel: 
  viral release. Apparent escape of a nucleocapsid (arrowhead) 
from a phagosome into the cytoplasm (cy) proximal to the 
  nucleus (nu), bar, 0.6 μm.PHAGOCYTOSIS-LIKE UPTAKE OF HSV-1 • CLEMENT ET AL. 1019
could vary with cell types as well. For instance, gD, the most 
studied glycoprotein, has been reported to bind multiple cellular 
molecules including three very diverse cellular receptors (Spear 
et al., 2000). Given the multi-protein binding ability of HSV-1 
envelope proteins and the potential for cell type–dependent 
  interactions, it is evident that extensive amount of work needs to 
be followed to identify the initial players and dissect their func-
tions in the triggering mechanism(s). In any case, our current 
study provides new information on the existence of a novel 
pathway with implications for virus entry into both professional 
and nonprofessional phagocytes. It also provides new informa-
tion on the poorly understood infection of the stroma and is 
likely to help develop new therapies for control of potentially 
blinding HSK.
Materials and methods
Plasmids
Plasmids used include gD receptors pBG38 (nectin-1) and pBEC10 
(HVEM); control vector pcDNA3 (Invitrogen); pNec1-EGFP or pHVEM-
EGFP expressing full-length nectin-1 or HVEM fused with EGFP (pEGFP-N1 
vector; BD Biosciences) and rat dynamin2 (wild-type, WT-dyn2 and dominant-
negative mutant, K44A-dyn2; from Mark McNiven, Mayo Clinic, Rochester, 
NY) fused with EGFP (CLONTECH Laboratories, Inc.). Eps15 mutants: 
DIII∆2 (control), DIII and EH29 corresponding to E∆95/295 all subcloned 
in EGFP-C2 were kind gifts from Alexandre Benmerah (Universite  ˙ Paris, 
Paris, France).
Cell culture and virus preparations
Patricia G. Spear (Northwestern University, Chicago, IL) provided wild-
type CHO-WT and CHO-745 cells (Esko et al., 1985). All CHO cell lines 
were grown in Ham’s F12 (Invitrogen) supplemented with 10% fetal bovine 
serum (FBS). Stable nectin-1 (or HVEM)-CHO or control empty vector 
pcDNA3 cell lines were selected in medium containing geneticin (500 
μg/ml) (Cellgro). For primary cultures of CF and TM cells, human eye tis-
sues were obtained from the Illinos Eye Bank and cultured as described 
previously (Yue and Baum, 1981). Recombinant viruses HSV-1(KOS) gL86 
and K26GFP (gifts from P. Desai, The Johns Hopkins University, Baltimore, 
MD) were ampliﬁ   ed and quantitated as described elsewhere (Desai 
and Person, 1998; Shukla et al., 2000). HHV-8 virions were a kind gift 
from J. Vieira (University of Washington, Seattle, WA). A syn mutant strain, 
HSV-1(KOS) 804 was harvested from Vero cells. HSV-1(KOS) gL86 was puri-
ﬁ  ed by a modiﬁ  ed sucrose gradient centrifugation method (Pignatti and 
Cassai, 1980). Experiments discussed in this manuscript were performed 
using HSV-1 titers within the linear range of 0–100 PFU/cell (Fig. 1 B).
Virus entry assays
Entry assays were based on quantitation of β-gal expressed from HSV-1 
genome by either insoluble 5-bromo-4-chloro-3-indoyl-β-D-galactoside 
(X-Gal; Invitrogen), 1 mg/ml or soluble O-nitro-phenyl β-D-galactopyranoside 
(ONPG; Pierce Biotechnology), 3 mg/ml. Alternatively, virus entry was de-
termined by ﬂ  uorescence readout assay.
Stably transfected nectin-1 (or HVEM)-CHO cells, CF, and TM cells 
were treated with medium containing Cyto D (0.5 or 1.0 μg/ml), Lat B 
(0.25 or 2.5μM), BFLA-1 (0.01 or 0.1 μM), chloroquine (1.0 or 100 μM), 
genistein (400 μM) (Sigma-Aldrich), or wortmannin (100 nM; Calbio-
chem). CF and TM cells were in addition treated with ammonium chloride 
(10 or 50 mM; Fisher cientiﬁ  c). Infected (HSV-1 at 50 PFU/cell used for all 
experiments unless otherwise stated) and mock-infected cells were grown 
for 24 h at 37°C in 96-well culture dishes. Dosages of pharmacological 
agents for treatments were based on prior reports (Spector et al., 1989; 
Gottlieb et al., 1993; Fredericksen et al., 2002; Nicola et al., 2003).
Quantitative real time PCR
Real-time quantitative PCR was performed in 25-μl tubes with DNA pre-
pared according to the manufacturer’s instruction (QIAamp DNA Mini kit) 
using a Smart Cycler System (Cepheid). Primers, forward; A  A  G  A  C  C  T  T  C  C-
G  G  T  C  C  T  G   and backward; T  C  C  A  A  C  A  C  G  G  C  G  T  A  G  T  A   for the HSV-1 
(KOS) glycoprotein D target were designed using Clone Manager 6 pro-
gram (Sci Ed Central). The reaction was performed for 50 cycles under the 
following conditions: denaturation at 95°C for 30 s, annealing at 58°C for 
10 s and extension at 72°C for 16 s. After ampliﬁ  cation, one cycle of melt-
ing curve from 60 to 95°C by a transition rate of 0.2°C/s with continuous 
detection of ﬂ  uorescence, was performed.
Confocal microscopy
Conﬂ  uent monolayers of cells grown on coverslips were transfected with 
nectin-1-EGFP plasmid. After 24 h, cells were incubated with Texas red-
transferrin conjugate (1:250 dilution; Molecular Probes) for 10 min and 
washed. Cells were then either infected with puriﬁ  ed HSV-1 for 30 min or 
mock-infected with phosphate-buffered saline  –glucose-calf serum (PBS-G-CS). 
At various times after infection, the cells were rinsed with PBS and 
ﬁ   xed with 4% paraformaldehyde. In another set of experiments, HSV-1 
was replaced with K26GFP and coincubated with ﬂ  uospheres sulfate (red 
beads) (Molecular Probes). Immunoﬂ  uorescence staining was done with 
anti EEA1, LAMP-2 (BD Biosciences), anti TfR (Zymed Laboratories) and 
counterstaining was performed using Cy3 anti–mouse secondary antibody 
(Jackson ImmunoResearch Laboratories). Confocal microscopy and se-
quential confocal analyses were performed using a laser-scanning spec-
trum confocal system (TCS SP2; Leica) linked to a microscope (DMIRE2; 
Leica). Images were captured using a 100× oil objective (Plan-Apo 1.4) 
with PMT for GFP and Cy3 at room temperature and using confocal acqui-
sition software, LCS (Leica). The laser intensities for the two channels were 
separately set by alternately lowering each laser intensity to eliminate cross 
talk between red and green. The full area was scanned in slow mode, with 
high resolution and a sampling time of 400 ns (2 s/image). The confocal 
slit was set at 10 μm in most cases. Images of the cells were collected in 
  focal planes with photomultiplier tubes. Images were processed using the 
LCS software. Additional sample stainings were analyzed using a ﬂ  uores-
cent microscope system (Zeiss Axiovert 100 M; Carl Zeiss MicroImaging, 
Inc.). Images were captured using a 63× oil objective (Plan-Apo 1.4) at 
room temperature using FITC, Cy3, and DAPI channels using a Cook 
  camera (SensiCam) and MetaMorph 6.3 software.
For some of the images, adjustments of brightness and contrast were 
applied to the entire images using Photoshop CS2 (Adobe).
Phagocytosis assay
The vibrant phagocytosis kit (Molecular Probes) developed with an adher-
ent murine macrophage cell line (J774) has been adapted to evaluate 
phagocytosis in other adherent cell types (Wan et al., 1993; Foukas et al., 
1998). Subcultured nectin-1-CHO, HVEM-CHO, and CHO-745 cells were 
adjusted to 10
6 cells/ml, aliquoted at 0 (negative control), 100 μl/micro-
well for positive and test into Microtest 96-well assay plates (BD Falcon) for 
settlement and adherence overnight at 37°C. The cells were washed and 
challenged with puriﬁ  ed HSV-1 or puriﬁ  ed K26GFP for test and PBS-G-CS 
for negative and positive controls. All cells were incubated at 4°C for 1 h, 
washed, and with warm medium further incubated at 37°C for 1 h. In ex-
periments using HSV-1, all the microwells were in addition challenged for 2 h 
with reconstituted suspension of ﬂ  uorescein-labeled E. coli K-12 bioparticles. 
For colocalization experiments, K26GFP and red ﬂ   uorescent beads 
(FluoSpheres; Molecular Probes) were used. The effect of dynamin was 
evaluated by transfecting cells with WT-dyn2 or K44A-dyn2. For drug inhi-
bition of internalization and phagocytosis, cells were ﬁ  rst cold-bound with 
puriﬁ  ed K26GFP or HSV-1 for 1 h before the 2-h incubation with virus in the 
presence of Cyto D (1 μg/ml) or Lat B (2.5 μM) at 37°C for post-treatment, 
or the cells were ﬁ  rst incubated for 1 h with the drugs for pre-treatment. 
  Virus that were bound to the cell surface were stripped with citrate buffer 
pH 3.0 for 1 min. Virus entry or phagocytic activity measured as relative 
ﬂ  uorescence units (RFU) per treatment were determined by a ﬂ  uorescence 
quenching assay with trypan blue using GENios Pro plate reader (TECAN) 
at 480-nm excitation and 520-nm emission spectrum. Measurements of 
ﬁ  ve replicates of negative control, positive control, and test samples were 
performed. Data were expressed as mean ± SD.
Electron microscopy
Nectin-1-CHO, CF, and TM cells cultured in Lab-Tek chamber slides (2.5 × 
10
5 cell/tray) and in anopore wells (Nalge Nunc) (2.5 × 10
5 cells/well) 
were infected with puriﬁ  ed HSV-1 at 10–100 PFU/cell for 10–90 min. EM 
was performed using standard methods (Nicola et al., 2003). For TEM 
(JEM-1220; JEOL USA Inc.), images were captured at 1,000–600,000×, 
point-0.36 nm (3.6A) and lattice-0.2 nm (2A) at temperature, ACC voltage 
40–120 kV using a Gatan camera (Digital CCD; Gatan, Inc.) and using 
Gatan Digital Micrograph (DM) v2.5 acquisition software. For SEM, Field 
Emission SEM (JMS-6320F; JEOL Inc. USA) was used to capture images 
at 25–2,000× in LM and 500–650,000× in HR modes. Images were JCB • VOLUME 174 • NUMBER 7 • 2006  1020
  resolved at 15 kV 1.2 nm (12A) and 1 kV 2.5 nm (25A) at room tempera-
ture ACC 0.5–30 kV using camera system ARC64 and Arch software 
(JEOL Inc. USA). Alternatively, for immunogold the infected cells were 
  processed (Spaur and Moriarty, 1977). Specimens mounted on 150 mesh 
nickel-formvar–coated grids were incubated in 1% BSA and further incu-
bated at room temperature for 3 h with polyclonal rabbit anti-HSV-1 gD, R7 
(1:200), or anti gH-gL, R137 (1:200). Sections were subsequently incu-
bated at room temperature for 1 h with 12-nm colloidal gold-conjugated 
goat anti–rabbit IgG (H+L) (1:30; Jackson ImmunoResearch Laboratories). 
The grids were also counterstained with uranyl acetate and examined in 
TEM as previously described.
Pull-down assays and Western blot analysis
Total cell lysates of equal amount of HSV-1 (50 PFU/cell for 15 min) or 
GDP (negative control) and GTPγS (positive control) as well as time courses 
for RhoA, Cdc42, and Rac) were spun in a microfuge at 14,000 rpm for 
15 min and proteinase inhibitors were added to the supernatants. Rhotekin-
RBD-GST (RhoA) and PAK-PBD-GST (Cdc42/Rac) beads (Cytoskeleton Inc.) 
were incubated with the supernatants for 1 h at 4°C on a rotator to 
bind the active proteins. The bound proteins were resolved on SDS-PAGE 
gels, transferred to nitrocellulose membranes, and immunoblotted with 
  antibodies; RhoA, Cdc42, Rac 1:200 (Santa Cruz Biotechnology) and 
secondary at 1:10,000 HRP anti–mouse IgG (for RhoA) and HRP anti–rabbit 
IgG (for Cdc42 and Rac) (Jackson ImmunoResearch Laboratories). 
  Immunoreactive bands were developed by West Pico substrate for 
  enhanced chemiluminescence reactions (Pierce Biotechnology) and 
imaged on KODAK Biomax Mr ﬁ  lm.
Online supplemental material
Fig. S1 shows plaque formation on CF cells after infection with HSV-1(KOS-
804). Fig. S2 shows large sections of CF, nectin-1-CHO, and TM cells after 
infection with HSV-1. Fig. S3 shows inactivation of uninternalized HSV-1 
after treatment with citrate buffer (pH 3.0). Fig. S4 shows the effects of ty-
rosine kinase and PI3K inhibitors on HSV-1 entry. Fig. S5 shows phalloidin 
staining of actin of nectin-1-CHO and CHO-WT cells demonstrating HSV-1 
induced cytoskeletal changes. Online supplemental material available at 
http://www.jcb.org/cgi/content/full/jcb.200509155.
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